Program

Welcoming Reception
The residence of
H.E. U.S. Ambassador Michael M. Wood
Nobelgatan 2, Stockholm.
Welcoming remarks
Ms Barbro C. Ehnbom,
Chairman SALSS

Registration

Setting the stage Moderator, Udayan Gupta,
WSJ Journalist and Author
View biografy about Udayan Gupta »

Introductory remarks
Kerstin Eliasson,
State Secretary, Ministry of Education, Research and Culture

Keynote address
Dr. William Haseltine,
Chairman, Haseltine Global Health;
Founder, Human Genome Sciences

Break

Panel
Commercialization
From research to business - Success stories
Moderator: Udayan Gupta
Some Swedish Case Studies
Professor Mathias Uhlén,
Royal Institute of Technology
Panel
Perspective - Institute of Higher Learning
Professor Harriet Wallberg-Henriksson,
President, Karolinska Institute
The Accelerated Growth Perspective
Dr. Yuval Binur,
General Partner, Accelerated Technologies
From Bench to Profit
Cynthia Ekberg Tsai,
Managing Director, Madelin Fund, MD Andersonbr /> Venture Capital Perspective
Dr. Eugen Steiner,
Partner, HealthCap

Break

The Swedish landscape – Company presentations
In separate presentation rooms: Affibody, BioGaia, Swedish Orphan

Lunch
Welcome: Charlotte Erkhammar,
CEO, Kreab Group
Lunch speaker: Tony Svensson,
Director ISA, New York

Delivering Growth Through Successful M&A
John T. Humphreys,
Principal, Bank of America

A Swedish Success Story
Dr. Laurent Leksell,
Director, Elekta
View article from InVivo »

Break

Panel
Internationalization –
Success Stories
Moderator: William Gedale,
Managing Partner, NGN BioMed, L.P.
Panel
Biacore GE Strategy
Peter Ehrenheim,
CEO, GE Healthcare Bio-Sciences
I.P. Perspective
Peter Utterström,
Delphi & Co.
Perspective from Down Under
Professor Vicki Sara,
Chair, Australian Stem Cell Center
Analyst's Perspective, the Life Science Market in Scandinavia
Benjamin Nordin,
Head Analyst, Kaupthing bank
Equity into Early Stage
J. Jay Lobell,
President, Paramount BioSciences

Concluding remarks by moderator

Dinner Cruise around Stockholm

Coffee reception

Keynote speaker
Professor Hans Wigzell,
Scientific Advisor to the Swedish Government

The Swedish landscape –
Company Presentations
Biolipox, LinkMed, Neuronova

Focus
This years topic - Life Science and the Developing World, from Bird Flu and the vaccines to the market potential in India and China
Moderator: Udayan Gupta

Special Appearance
What's going on in Washington
Senator Larry L. Pressler (Ret.)
Panel
Big corporate perspective
Niklas Prager,
CEO, Pfizer Sweden
The Investors Persepective
Mikael Brönnegård,
Director, HealthCare, InnKap
Investing in China through the U.S. public markets
Dr. Robin L. Smith,
CEO and Chairman, Phase 3 Medical / NeoStem
Global Overview
Staffan Folin,
Partner, Ernst & Young
From antiterrorism to cancer
Dr. Michael Fonstein,
President, Cleveland BioLabs

Break

Company presentations
In separate presentation rooms:
Bionovo (U.S.), Medivir, NeoStem (U.S.)

Final Remarks - Moderator

Lunch at Grand Hôtel
Hosted by Kaupthing Bank